Abstract 16099: Predictors of Cardiovascular Implantable Electronic Device-dependence at Long-term Follow-up After Alcohol Septal Ablation in Hypertrophic Cardiomyopathy Patients
Weeranun D. Bode(St David's Medical Center), Theofanie Mela(Massachusetts General Hospital), Michael F. Bode(Massachusetts General Hospital), Rahul Sakhuja(Harvard University), Megan Zhao(University of Pennsylvania), Michael A. Fifer(Massachusetts General Hospital)
Cited by 0
Related Papers
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
|Circulation|2011|2.1k
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
|Journal of the American College of Cardiology|2011|1.3k
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary
|Circulation|2011|820
2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy
|Journal of Thoracic and Cardiovascular Surgery|2011|327
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary
|Journal of the American College of Cardiology|2011|278